Adverse Pregnancy Outcomes Are Associated with Incident Peripheral Artery Disease, Results from the Women’s Health Initiative.
Abstract Body (Do not enter title and authors here): Background: Women with a history of adverse pregnancy outcomes (APOs) have an increased risk for heart disease and stroke; however, data on risk for peripheral arterial disease (PAD) are scarce.
Hypothesis: We hypothesized that women with a history of an APO were at greater risk for incident PAD.
Methods: Data from the Women’s Health Initiative, which enrolled 161,808 postmenopausal women, aged 50-79 years, between 1993 and 1998, were used for the present analysis. Participants who completed survey items in 2017 on APO history were eligible for this study. Incident PAD was defined as ≥ one of the following in a lower extremity artery: stenosis or ulceration (≥50% diameter or ≥75% cross-sectional area) on imaging; absence of arterial pulse by Doppler; claudication on exercise testing; surgery, angioplasty or thrombolysis for PAD; amputation of or part of the lower extremity due to ischemia or gangrene; physician diagnosed claudication; or an ankle-brachial index (ABI) of ≤ 0.8. Events were adjudicated from baseline to 2010. Participants were eligible for this analysis if they did not have a history of PAD at baseline, had ≥1 pregnancy lasting >6 months, and had non-missing data on APOs (n=47,370). Multivariable models examined the association between APOs and incident PAD, adjusting for age, race/ethnicity, education, income, physical activity, diet, sleep, and alcohol intake.
Results: A history of APOs was reported by 13,666 women (28.8%), with 8,325 reporting one APO and 5,341 reporting two or more APOs. The most common APO reported was pre-term delivery (6,910 [14.6%]), followed by low birth weight (5,866 [12.4%]). Women who reported at least one APO had higher odds for incident PAD (adjusted odds ratio [aOR] 2.02, 95% confidence interval [CI] 1.43-2.85) compared to women without an APO. Individual APOs including gestational hypertension/preeclampsia (aOR 2.31, 95% CI 1.35-3.95), low birth weight (aOR 2.50, 95% CI 1.71-3.66), and preterm delivery (aOR 1.71, 95% CI 1.15-2.56) were associated with incident PAD, while gestational diabetes demonstrated a higher, but nonsignificant, odds for PAD (aOR 1.87, 95% CI 0.68-5.12).
Conclusion: In this large cohort of multiethnic women, APOs were associated with a doubled risk for incident PAD. Gestational hypertension/preeclampsia, low birth weight, and preterm delivery were independently associated with incident PAD. Additional research is warranted to understand the underlying mechanisms linking APOs and PAD.
Jackson, Elizabeth
( University of Alabama at Birmingham
, Birmiham
, Alabama
, United States
)
Leblanc, Erin
( Kaiser Permanente Washington
, Seattle
, Washington
, United States
)
Haring, Bernhard
( Saarland University
, Saarbrücken
, Germany
)
Harrington, Laura
( Kaiser Permanente Washington
, Seattle
, Washington
, United States
)
Allison, Matthew
( University of California San Diego
, San Diego
, California
, United States
)
Eaton, Charles
( Brown University
, Providence
, Rhode Island
, United States
)
Lamonte, Michael
( University at Buffalo - SUNY
, Buffalo
, New York
, United States
)
Hovey, Kathleen
( University at Buffalo - SUNY
, Buffalo
, New York
, United States
)
Andrews, Chris
( University at Buffalo - SUNY
, Buffalo
, New York
, United States
)
Wells, Gretchen
( University of Alabama at Birmingham
, Birmiham
, Alabama
, United States
)
Manson, Joann
( Harvard Medical School
, Boston
, Massachusetts
, United States
)
Levitan, Emily
( UNIVERSITY ALABAMA AT BIRMINGHAM
, Birmingham
, Alabama
, United States
)
Spracklen, Cassandra
( UNIVERSITY OF Massaschusetts
, Amherst
, Massachusetts
, United States
)
Wild, Robert
( OU HEALTH SCIENCES CTR
, Oklahoma City
, Oklahoma
, United States
)
Author Disclosures:
Elizabeth Jackson:DO NOT have relevant financial relationships
| Erin LeBlanc:No Answer
| Bernhard Haring:DO have relevant financial relationships
;
Speaker:Bristol Myers Squibb:Past (completed)
; Speaker:Boehringer Ingelheim:Past (completed)
; Speaker:Daiichi Sankyo:Past (completed)
; Speaker:Inari:Past (completed)
; Speaker:Pfizer:Active (exists now)
| Laura Harrington:DO NOT have relevant financial relationships
| Matthew Allison:No Answer
| Charles Eaton:DO NOT have relevant financial relationships
| Michael LaMonte:DO NOT have relevant financial relationships
| Kathleen Hovey:No Answer
| Chris Andrews:No Answer
| Gretchen Wells:No Answer
| JoAnn Manson:No Answer
| Emily Levitan:DO have relevant financial relationships
;
Research Funding (PI or named investigator):Amgen:Past (completed)
| Cassandra Spracklen:No Answer
| Robert Wild:No Answer